Who
Jerome J. Dvonch
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Sonoma Pharmaceuticals.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Jan 2021
- Last trade
- 9 Jul 2026
- Last filed
- 9 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jul 2026filed 9 Jul 2026 | SNOA Sonoma Pharmaceuticalsoption or derivative · Medical Devices | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 9 Jul 2026filed 9 Jul 2026 | SNOA Sonoma Pharmaceuticalsoption or derivative · Medical Devices | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 2 Jan 2026filed 2 Jan 2026 | SNOA Sonoma Pharmaceuticalsoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 2 Jan 2026filed 2 Jan 2026 | SNOA Sonoma Pharmaceuticalsoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 19 Jun 2025filed 20 Jun 2025 | SNOA Sonoma Pharmaceuticalsoption or derivative · Medical Devices | SEC FORM 4 Code A | —13,500 at $0.00 | filing |
| 2 Jan 2025filed 3 Jan 2025 | SNOA Sonoma Pharmaceuticalsoption or derivative · Medical Devices | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 20 Jun 2024filed 21 Jun 2024 | SNOA Sonoma PharmaceuticalsMedical Devices | SEC FORM 4 Code A | —53,586 | filing |
| 29 Dec 2023filed 29 Dec 2023 | SNOA Sonoma Pharmaceuticalsoption or derivative · Medical Devices | SEC FORM 4 Code A | —60,000 | filing |
| 14 Jan 2022filed 14 Jan 2022 | SNOA Sonoma Pharmaceuticalsoption or derivative · Medical Devices | SEC FORM 4 Code A | —30,000 | filing |
| 7 Jan 2021filed 8 Jan 2021 | SNOA Sonoma Pharmaceuticalsoption or derivative · Medical Devices | SEC FORM 4 Code A | —27,777 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.